PDSB - PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q4 2021 Results - Earnings Call Transcript
PDS Biotechnology Corporation (PDSB) Q4 2021 Results Earnings Conference Call March 31, 2022, 08:00 AM ET Company Participants Gabrielle DeGravina - Investor Relations, CG Capital Frank Bedu-Addo - Chief Executive Officer Lauren Wood - Chief Medical Officer Matthew Hill - Chief Financial Officer Conference Call Participants Louise Chen - Cantor Fitzgerald Leland Gershell - Oppenheimer James Molloy - Alliance Global Partners Joseph Pantginis - H. C. Wainwright Robert LeBoyer - Noble Capital Markets Presentation Operator Greetings and welcome to PDS Biotechnology Fourth Quarter 2021 Earnings Call and Webcast. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded. It's now my pleasure to turn the conference over to Gabby DeGravina. Please go ahead. Gabrielle DeGravina Good morning. And welcome to PDS Biotechnology's fourth quarter and full-year 2021 earnings conference call and audio
For further details see:
PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q4 2021 Results - Earnings Call Transcript